While our data are based on measurements from the late 1990s, they offer a valuable foundation for informing population-specific screening strategies aimed at earlier identification of individuals at increased ASCVD risk due to elevated Lp(a) in Germany. This evidence concerns the gene LPA and atherosclerosis.